#United States #Spinal Cord Injury #Libertyville #Closed System Catheters #Hollister Incorporated

Hollister Incorporated's Policy Change

Hollister Incorporated has recently made headlines with a significant policy update that stands to benefit many Medicare beneficiaries suffering from spinal cord injuries (SCIs). This transformative action comes as the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) agree to enhance access to closed system intermittent catheters, which are essential for preventing urinary tract infections (UTIs) and ensuring the overall health of their users.

A Landmark Development in Healthcare

For over five decades, patients with SCIs and on Medicare have faced stringent barriers, requiring them to endure multiple urinary tract infections before qualifying for closed system intermittent catheters. The previous policy not only delayed necessary medical care but also jeopardized the health and dignity of countless patients. Hollister has long been an advocate for these individuals, championing a cause that emphasizes prevention over mere treatment. Their president and CEO, Abinash Nayak, highlighted that this policy modification is not just a victory; it reflects Hollister's commitment to making life more fulfilling for users of their products.

A Journey of Advocacy and Change

Three years ago, a dedicated campaign spearheaded by Casey Haan, Senior Director of Market Access and Government Affairs at Hollister, aimed to dismantle these long-standing barriers. Through persistent advocacy, the company worked hand-in-hand with DME MACs to modify the coverage criteria, ensuring equitable access to essential medical devices for those who need them the most. Effective January 1, 2026, any Medicare beneficiary diagnosed with a spinal cord injury at any level will automatically qualify for a closed system intermittent catheter, erasing decades of outdated restrictions.

Implications of the Change

This recent change in policy has profound implications for patients and healthcare professionals alike. For patients, it means timely access to crucial medical devices designed to enhance health and improve quality of life. Importantly, the new policy encourages greater independence and offers users the dignity they deserve. Furthermore, healthcare professionals will benefit from a streamlined process for prescribing and managing care, allowing for improved delivery and oversight.

As Casey Haan expressed, this pivotal reform signifies a major advancement in Continence Care and patient advocacy. It enhances the ability of clinicians and patients alike to select appropriate products based on individual needs, fostering a more personalized approach to healthcare.

Commitment to Future Innovations

Hollister's strides towards improving healthcare access reflect its unwavering dedication to innovation and patient advocacy. The recent policy update is a testament to the company’s promise to drive change that uplifts lives and cultivates healthcare equity. With a rich history of over 100 years, Hollister has maintained its status as a leader in medical technology, continually striving to set new benchmarks in compassionate care.

This change is not just about medical devices; it represents a commitment to ongoing support and advocacy for individuals with substantial healthcare needs. Hollister remains resolute in its mission to empower those who rely on its products and to expand initiatives that transform lives for the better.

About Hollister Incorporated

Hollister Incorporated is a global player in the MedTech sector, dedicated to ensuring that its impactful healthcare products elevate the dignity and quality of life for users worldwide. With over 5,000 employees across 24 countries, Hollister prides itself on its innovative approach to healthcare solutions, particularly in Ostomy, Continence Care, and Critical Care products. Their commitment is evident in every aspect of their work, driving positive change and marketplace transformations for more than a century.